| Original language | English |
|---|---|
| Pages (from-to) | 657-660 |
| Number of pages | 4 |
| Journal | Journal of Psychopharmacology |
| Volume | 36 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2022 |
Bibliographical note
Funding Information:The author thanks Lorraine Maw, M.A., for editorial assistance. The author is grateful to the reviewers who provided suggestions for improving the article. The author(s) received no financial support for the research, authorship, and/or publication of this article.
Funding
The author thanks Lorraine Maw, M.A., for editorial assistance. The author is grateful to the reviewers who provided suggestions for improving the article. The author(s) received no financial support for the research, authorship, and/or publication of this article.
| Funders |
|---|
| Lorraine Maw |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Pharmacology
- Psychiatry and Mental health
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'The history of clozapine in clinical practice: From its introduction to a guideline proposing personalized titrations'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver